| Characteristic | Equal | Patent longer | Orphan drug exclusivity longer |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Sources
Release date
December 2018
More information
Region
United States
Survey time period
as of November 2018
Number of respondents
503 respondents
Special properties
drugs with any approved orphan designation
Supplementary notes
ODE = orphan drug exclusivity.
Patent protection includes other forms of market exclusivity (e.g., pediatric extension, 505(b)(2)). Comparison of
latest patent and earliest orphan exclusivity dates as the determination of longer duration.
Citation formats
